Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
17.03.26
/
50%
€54.00
Target price
17.03.27
€65.24
Performance (%)
32.81%
Price
17:10
€71.72
Summary
This prediction is currently active. With a performance of 32.81% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 17.03.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 8.488% | 8.488% |
| iShares Core DAX® | 0,56 % | 0,44 % |
| iShares Nasdaq 100 | -0,16 % | 1,62 % |
| iShares Nikkei 225® | 1,10 % | 9,61 % |
| iShares S&P 500 | 0,01 % | 0,69 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by JPMorgan Chase & Co. from $74.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
09.06.25
09.06.25
€46.41
09.06.26
09.06.26
101.52%
10.06.26
10.06.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-9.31%
06.09.25
06.09.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€49.60
24.06.24
24.06.24
€60.52
24.06.25
24.06.25
-42.74%
25.06.25
25.06.25